Palvella Therapeutics, Inc. (PVLA) Net margin 2016–2023
Palvella Therapeutics, Inc. (PVLA) net profit margin by fiscal year — reported net income divided by reported revenue.
43.7%FY2023 · since FY2016: -391.0% → 43.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 43.7% | +172.1 pp |
| FY2022 | -128.5% | +17.1 pp |
| FY2021 | -145.6% | -18.6 pp |
| FY2020 | -127.0% | -68.6 pp |
| FY2019 | -58.4% | +39.8 pp |
| FY2018 | -98.2% | -28.4 pp |
| FY2017 | -69.8% | +321.2 pp |
| FY2016 | -391.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice